Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.

Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-07-08 Novo Holdings A/S 10%-Owner Sell 1,538,062 $5.31 $8,168,547 No
2019-07-25 Novo Holdings A/S 10%-Owner Sell 1,492,956 $4.07 $6,077,845 No
2018-03-12 Novo Holdings A/S 10%-Owner Buy 1,176,470 $8.50 $9,999,995 No
2017-06-23 Novo Holdings A/S 10%-Owner Buy 20,000 $10.95 $219,000 No
2016-05-12 Novo A/S 10%-Owner Buy 70,000 $10.00 $700,000 No
2016-03-29 Novo A/S 10%-Owner Buy 666,666 $15.00 $9,999,990 Yes

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!